About
Cleave Biosciences develops immuno-oncology therapies that use targeted protein cleavage to selectively degrade disease-causing proteins.
Explore Cleave Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.